CoSara begins India clinical studies of Co-Diagnostics’ rapid tuberculosis PCR test, but assay clearance and real-world validation remain ahead.
Read how Shantha Biologics’ Novo Nordisk cartridge fill-finish deal could reshape complex injectable manufacturing in India.
Gilead’s WHO pact targets kala-azar access, but diagnostics, treatment delivery and East Africa execution will decide the impact.
Align needs growth and supply-chain efficiency. Its Hyderabad factory could turn India into a larger digital dentistry manufacturing base.